FR2581873B1 - Preparations pharmaceutiques a activite anti-hypertensive et cardioprotectrice contenant du verapamil, du triamterene et de l'hydrochlorothiazide - Google Patents

Preparations pharmaceutiques a activite anti-hypertensive et cardioprotectrice contenant du verapamil, du triamterene et de l'hydrochlorothiazide

Info

Publication number
FR2581873B1
FR2581873B1 FR868607051A FR8607051A FR2581873B1 FR 2581873 B1 FR2581873 B1 FR 2581873B1 FR 868607051 A FR868607051 A FR 868607051A FR 8607051 A FR8607051 A FR 8607051A FR 2581873 B1 FR2581873 B1 FR 2581873B1
Authority
FR
France
Prior art keywords
hypertensive
triamterene
hydrochlorothiazide
pharmaceutical preparations
activity containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR868607051A
Other languages
English (en)
Other versions
FR2581873A1 (fr
Inventor
Klaus Lossnitzer
Karl-Friedrich Ober
Gerhard Giebenhain
Karl-Dieter Volger
Gerhard Zeiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roehm Pharma GmbH
Original Assignee
Roehm Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roehm Pharma GmbH filed Critical Roehm Pharma GmbH
Publication of FR2581873A1 publication Critical patent/FR2581873A1/fr
Application granted granted Critical
Publication of FR2581873B1 publication Critical patent/FR2581873B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR868607051A 1985-05-17 1986-05-16 Preparations pharmaceutiques a activite anti-hypertensive et cardioprotectrice contenant du verapamil, du triamterene et de l'hydrochlorothiazide Expired - Lifetime FR2581873B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853517820 DE3517820A1 (de) 1985-05-17 1985-05-17 Pharmazeutische praeparate mit antihypertensiver und kardioprotektiver wirkung

Publications (2)

Publication Number Publication Date
FR2581873A1 FR2581873A1 (fr) 1986-11-21
FR2581873B1 true FR2581873B1 (fr) 1993-01-15

Family

ID=6271008

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868607051A Expired - Lifetime FR2581873B1 (fr) 1985-05-17 1986-05-16 Preparations pharmaceutiques a activite anti-hypertensive et cardioprotectrice contenant du verapamil, du triamterene et de l'hydrochlorothiazide

Country Status (12)

Country Link
US (1) US5047235A (fr)
EP (1) EP0205865B1 (fr)
JP (1) JPH0678233B2 (fr)
AT (1) ATE44129T1 (fr)
AU (1) AU577947B2 (fr)
CA (1) CA1277916C (fr)
DE (1) DE3517820A1 (fr)
FR (1) FR2581873B1 (fr)
GB (1) GB2175206B (fr)
IL (1) IL78794A (fr)
IT (1) IT1215172B (fr)
ZA (1) ZA863653B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739779A1 (de) * 1987-11-24 1989-06-08 Beiersdorf Ag Pharmazeutische praeparate
DE3908232C2 (de) * 1989-03-14 1998-02-26 Roehm Pharma Gmbh Verwendung von Verapamil zur Behandlung der Schlaf-Apnoe
KR0169115B1 (ko) * 1989-03-22 1999-01-15 케이 티 팡 피터 부갑상선 고혈압성 인자
US5350771A (en) * 1989-03-22 1994-09-27 Peter K. T. Pang Method and treatment for hypertension using combination therapy involving exogenous calcium and calcium channel blockers
US5886012A (en) * 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
CN1049115C (zh) * 1993-01-01 2000-02-09 上海医科大学 防御心肺脑低氧损害的复方制剂
US6083532A (en) * 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
WO2005077418A1 (fr) * 2004-02-17 2005-08-25 Novartis Ag Combinaison d'un inhibiteur de la renine et de diuretiques
US8586104B2 (en) * 2008-04-10 2013-11-19 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essentially fatty acids derived from Salvia hispanica L. seed: composition of matter, manufacturing process and use
US8784904B2 (en) * 2008-04-10 2014-07-22 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2658500C2 (de) * 1976-12-23 1986-10-09 Knoll Ag, 6700 Ludwigshafen Pharmazeutische Präparate mit kardioprotektiver Wirkung
US4444769A (en) * 1982-07-27 1984-04-24 Mylan Pharmaceuticals, Inc. Antihypertensive diuretic combination composition and associated method
US4526777A (en) * 1983-01-06 1985-07-02 Mylan Pharmaceuticals Inc. Pharmaceutical combination composition and associated method

Also Published As

Publication number Publication date
FR2581873A1 (fr) 1986-11-21
DE3517820C2 (fr) 1992-07-30
DE3517820A1 (de) 1986-11-20
JPH0678233B2 (ja) 1994-10-05
ZA863653B (en) 1987-01-28
JPS61268624A (ja) 1986-11-28
CA1277916C (fr) 1990-12-18
GB2175206A (en) 1986-11-26
IT8667408A0 (it) 1986-05-16
US5047235A (en) 1991-09-10
GB8611946D0 (en) 1986-06-25
IL78794A (en) 1991-03-10
IT1215172B (it) 1990-01-31
AU577947B2 (en) 1988-10-06
ATE44129T1 (de) 1989-07-15
EP0205865A1 (fr) 1986-12-30
EP0205865B1 (fr) 1989-06-21
GB2175206B (en) 1989-01-11
AU5754686A (en) 1986-11-20

Similar Documents

Publication Publication Date Title
DE3689436T2 (de) Thiazolderivate und diese als wirksame Bestandteile enthaltender Leukotrien-Antagonist.
IT8619004A0 (it) Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
IL84855A (en) Hydrosols of pharmacologically active agents,their preparation and pharmaceutical compositions containing them
LU91037I2 (fr) Somatulina autogel
FR2602141B1 (fr) Composition pharmaceutique a activite analgesique contenant de l'ibuprofene comme principe actif
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
FR2581873B1 (fr) Preparations pharmaceutiques a activite anti-hypertensive et cardioprotectrice contenant du verapamil, du triamterene et de l'hydrochlorothiazide
KR910000703A (ko) 테트라졸 자극성 아미노산 수용체의 길항물질
BE893193A (fr) Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif
FR2598320B1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
DK607885D0 (da) Medikamentpraeparatet med formindsket giftighed
PT83556A (de) Biologisch aktive derivate des human-gama-interferons ihre herstellung und arzneimittel die solche derivate enthalten
FI944854A (fi) 3,4-dihydro-2H-1,2,4-bentsotiadiatsin-1,1-dioksidi-3-karboksyylihappojohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
JPS57144214A (en) Pharmaceutical preparation for rectum medication
DE3671630D1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
IT8621135A0 (it) Derivati dell'acito cef-3-em-4-carbossilico, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
FR2601950B1 (fr) N,n-dimethyl-n'-benzoyl-n' ((2,3-dihydro) benzofuran-2-yl-methyl) 1,3-propanediamine, preparation et compositions pharmaceutiques les contenant
IT8520514A0 (it) Composizioni di farmaci dotate di attivita' antimicrobica eprocedimento per la loro preparazione.
FR2710062B1 (fr) Dérivés d'acide 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur préparation et les médicaments les contenant.
IT1214915B (it) Derivato dell'acido 4-metossiisoftalico con attivita'farmacologica in disordini tromboembolici e procedimento per la sua preparazione
FR2577422B1 (fr) Association renfermant a titre de principes actifs, un analgesique central et l'adenine ou l'adenosine ou l'un des analogues de l'adenosine
KR870000071A (ko) 수의 운동을 개선하는 신규약제 조성물 및 그의 생산공정
FR2567755B1 (fr) Nouveau medicament anti-tumoral contenant comme ingredient actif le triacetoxy-1,8,9 anthracene
FR2690159B1 (fr) Derives d'acide 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur preparation et les medicaments les contenant.

Legal Events

Date Code Title Description
CD Change of name or company name
TP Transmission of property